Imax (IMAX) Given a $30.00 Price Target at Wedbush

Wedbush set a $30.00 price target on Imax (NYSE:IMAX) in a report published on Monday, January 8th. The firm currently has a buy rating on the stock. Wedbush also issued estimates for Imax’s Q4 2017 earnings at $0.29 EPS, FY2017 earnings at $0.25 EPS, Q1 2018 earnings at ($0.02) EPS, Q3 2018 earnings at $0.16 EPS, Q4 2018 earnings at $0.25 EPS and FY2018 earnings at $0.65 EPS.

IMAX has been the topic of several other research reports. Zacks Investment Research lowered Imax from a hold rating to a sell rating in a research note on Wednesday, October 11th. Credit Suisse Group dropped their price target on Imax from $26.00 to $25.00 and set a neutral rating on the stock in a research note on Thursday, September 28th. BidaskClub downgraded Imax from a hold rating to a sell rating in a report on Thursday, October 12th. Barrington Research raised Imax from a market perform rating to an outperform rating and set a $32.00 price target for the company in a report on Monday, October 30th. Finally, B. Riley set a $35.00 price target on Imax and gave the company a buy rating in a report on Thursday, October 19th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company’s stock. Imax has a consensus rating of Hold and a consensus target price of $29.30.

Shares of Imax (IMAX) opened at $19.85 on Monday. Imax has a 52-week low of $17.58 and a 52-week high of $34.60. The firm has a market capitalization of $1,246.53, a price-to-earnings ratio of 220.58, a PEG ratio of 1.13 and a beta of 1.13.

In other news, insider Mark Welton sold 8,985 shares of the stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $25.81, for a total value of $231,902.85. Following the transaction, the insider now owns 16,331 shares in the company, valued at approximately $421,503.11. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Robert D. Lister sold 3,528 shares of the firm’s stock in a transaction that occurred on Monday, December 11th. The stock was sold at an average price of $23.97, for a total value of $84,566.16. Following the transaction, the insider now owns 35,594 shares in the company, valued at approximately $853,188.18. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,050 shares of company stock worth $425,276. 18.90% of the stock is owned by corporate insiders.

Hedge funds have recently modified their holdings of the stock. Crow Point Partners LLC acquired a new position in Imax during the fourth quarter worth $103,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Imax by 13.0% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,522 shares of the company’s stock valued at $181,000 after purchasing an additional 748 shares during the period. BNP Paribas Arbitrage SA grew its position in shares of Imax by 1,151.0% in the second quarter. BNP Paribas Arbitrage SA now owns 6,818 shares of the company’s stock valued at $150,000 after purchasing an additional 6,273 shares during the period. Seven Eight Capital LP grew its position in shares of Imax by 1,115.7% in the second quarter. Seven Eight Capital LP now owns 7,294 shares of the company’s stock valued at $160,000 after purchasing an additional 6,694 shares during the period. Finally, Formula Growth Ltd. purchased a new stake in shares of Imax in the third quarter valued at $222,000. 83.04% of the stock is owned by hedge funds and other institutional investors.

WARNING: “Imax (IMAX) Given a $30.00 Price Target at Wedbush” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another site, it was copied illegally and republished in violation of US & international copyright & trademark law. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/01/imax-imax-given-a-30-00-price-target-by-wedbush-analysts.html.

Imax Company Profile

IMAX Corporation is an entertainment technology company. The Company operates through seven segments: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production, and other. The IMAX systems segment designs, manufactures, sells or leases IMAX theater projection system equipment.

Analyst Recommendations for Imax (NYSE:IMAX)

Receive News & Ratings for Imax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imax and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply